The role of molecular genetic alterations in sensitivity of the adjuvant intravesical therapy for non-muscle invasive bladder cancer-Reference-Cited by-同舟云学术

The role of molecular genetic alterations in sensitivity of the adjuvant intravesical therapy for non-muscle invasive bladder cancer

Published:2019-01-15 Issue:4 Volume:14 Page:124-138
ISSN:1996-1812
Container-title:Cancer Urology
language:
Short-container-title:Onkourologiâ

Author:

Mikhaylenko D. S.¹^ORCID,Sergienko S. A.²,Zaborsky I. N.³^ORCID,Saflullin K. N.³,Serebryany S. A.²,Safronova N. Yu.²,Nemtsova M. V.⁴^ORCID,Kaprin A. D.²^ORCID,Alekseev B. Ya.²^ORCID

Affiliation:

1. N.A. Lopatkin Research Institute of Urology and Interventional Radiology — branch of the National Medical Research Radiological Center, Ministry of Health of Russia; Sechenov First Moscow State Medical University, Ministry of Health of Russia; Research Centre for Medical Genetics

2. N.A. Lopatkin Research Institute of Urology and Interventional Radiology — branch of the National Medical Research Radiological Center, Ministry of Health of Russia

3. A. Tsyb Medical Radiological Research Center — branch of the National Medical Research Radiological Center, Ministry of Health of Russia

4. Sechenov First Moscow State Medical University, Ministry of Health of Russia; Research Centre for Medical Genetics

Publisher

Publishing House ABV Press

Subject

Urology,Nephrology,Radiology, Nuclear Medicine and imaging,Oncology,Surgery

Reference75 articles.

1. Malignant tumors in Russia in 2016 (morbidity and mortality). Eds.: A.D. Kaprin, V.V. Starinskiy, G.V. Petrova. Moscow: MNIOI im. P.A. Gertsena - filial FGBU “NMIRTS” Minzdrava Rossii, 2018. 250 p. (In Russ.).

2. Ferlay J., Soerjomataram I. Dikshit R. et al. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Can-cer 2015;136(5):E359—86. DOI: 10.1002/ijc.29210. PMID: 25220842.

3. Comperat E., Larre S., Roupret M. et al. Clinicopathological characteristics of urothelial bladder cancer in patients less than 40 years old. Virchows Arch 2015;466(5):589—94. DOI: 10.1007/s00428-015-1739-2. PMID: 25697540.

4. Freedman N.D., Silverman D.T., Hollenbeck A.R. et al. Association between smoking and risk of bladder cancer among men and women. JAMA 2011;306(7):737— 45. DOI: 10.1001/jama.2011.1142. PMID: 21846855.

5. Burger M., Catto J.W., Dalbagni G. et al. Epidemiology and risk factors of urothelial bladder cancer. Eur Urol 2013;63(2): 234—41. DOI: 10.1016/j.eururo.2012.07.033. PMID: 22877502.

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The number of cancer stem cells in the tumor tissue and perifocal tissue of non-muscle invasive bladder cancer;South Russian Journal of Cancer;2022-02-21

2. Markers of bladder cancer: their role and prognostic significance (literature review);Cancer Urology;2021-07-25

3. Markers of bladder cancer: their role and prognostic significance (literature review);ONKOUROLOGIYA;2021

4. Study of association between molecular marker expression on tumor and immunocompetent cells and sensitivity to adjuvant and neoadjuvant therapy of bladder cancer;Cancer Urology;2019-07-09